> top > projects > Inflammaging > docs > PubMed:2014945 > annotations

PubMed:2014945 JSONTXT 7 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T1 0-83 Sentence denotes Risk factors for infusion-related phlebitis with small peripheral venous catheters.
T1 0-83 Sentence denotes Risk factors for infusion-related phlebitis with small peripheral venous catheters.
T2 84-114 Sentence denotes A randomized controlled trial.
T2 84-114 Sentence denotes A randomized controlled trial.
T3 115-125 Sentence denotes OBJECTIVE:
T3 115-125 Sentence denotes OBJECTIVE:
T4 126-220 Sentence denotes To identify risk factors for infusion-related phlebitis with peripheral intravenous catheters.
T4 126-220 Sentence denotes To identify risk factors for infusion-related phlebitis with peripheral intravenous catheters.
T5 221-228 Sentence denotes DESIGN:
T5 221-228 Sentence denotes DESIGN:
T6 229-323 Sentence denotes A randomized trial of two catheter materials, with consideration of 21 potential risk factors.
T6 229-323 Sentence denotes A randomized trial of two catheter materials, with consideration of 21 potential risk factors.
T7 324-332 Sentence denotes SETTING:
T7 324-332 Sentence denotes SETTING:
T8 333-355 Sentence denotes A university hospital.
T8 333-355 Sentence denotes A university hospital.
T9 356-365 Sentence denotes PATIENTS:
T9 356-365 Sentence denotes PATIENTS:
T10 366-458 Sentence denotes Hospitalized adults without granulocytopenia who received a peripheral intravenous catheter.
T10 366-458 Sentence denotes Hospitalized adults without granulocytopenia who received a peripheral intravenous catheter.
T11 459-473 Sentence denotes INTERVENTIONS:
T11 459-473 Sentence denotes INTERVENTIONS:
T12 474-707 Sentence denotes House officers or ward nurses inserted the catheters, and each insertion was randomized to a catheter made of tetrafluoroethylene-hexafluoropropylene (FEP-Teflon) or a novel polyetherurethane without leachable additives (PEU-Vialon).
T12 474-707 Sentence denotes House officers or ward nurses inserted the catheters, and each insertion was randomized to a catheter made of tetrafluoroethylene-hexafluoropropylene (FEP-Teflon) or a novel polyetherurethane without leachable additives (PEU-Vialon).
T13 708-721 Sentence denotes MEASUREMENTS:
T13 708-721 Sentence denotes MEASUREMENTS:
T14 722-821 Sentence denotes Research nurses scored insertion sites each day for inflammation and cultured catheters at removal.
T14 722-821 Sentence denotes Research nurses scored insertion sites each day for inflammation and cultured catheters at removal.
T15 822-830 Sentence denotes RESULTS:
T15 822-830 Sentence denotes RESULTS:
T16 831-1226 Sentence denotes The Kaplan-Meier risk for phlebitis exceeded 50% by day 4 after catheterization. intravenous antibiotics (relative risk, 2.00), female sex (relative risk, 1.88), prolonged (greater than 48 hours) catheterization (relative risk, 1.79), and catheter material (PEU-Vialon: FEP-Teflon) (relative risk, 0.73) strongly predicted phlebitis in a Cox proportional hazards model (each, P less than 0.003).
T16 831-1226 Sentence denotes The Kaplan-Meier risk for phlebitis exceeded 50% by day 4 after catheterization. intravenous antibiotics (relative risk, 2.00), female sex (relative risk, 1.88), prolonged (greater than 48 hours) catheterization (relative risk, 1.79), and catheter material (PEU-Vialon: FEP-Teflon) (relative risk, 0.73) strongly predicted phlebitis in a Cox proportional hazards model (each, P less than 0.003).
T17 1227-1502 Sentence denotes The best-fit model for severe phlebitis identified the same predictors plus catheter-related infection (relative risk, 6.19), phlebitis with a previous catheter (relative risk, 1.54), and anatomic site (hand: forearm, relative risk, 0.71; wrist:forearm, relative risk, 0.60).
T17 1227-1502 Sentence denotes The best-fit model for severe phlebitis identified the same predictors plus catheter-related infection (relative risk, 6.19), phlebitis with a previous catheter (relative risk, 1.54), and anatomic site (hand: forearm, relative risk, 0.71; wrist:forearm, relative risk, 0.60).
T18 1503-1730 Sentence denotes The low incidence of local catheter-related infection was comparable with the two catheter materials (5.4% [95% CI, 3.8% to 7.6%] and 6.9% [CI, 4.9% to 9.6%]); none of the 1054 catheters prospectively studied caused bacteremia.
T18 1503-1730 Sentence denotes The low incidence of local catheter-related infection was comparable with the two catheter materials (5.4% [95% CI, 3.8% to 7.6%] and 6.9% [CI, 4.9% to 9.6%]); none of the 1054 catheters prospectively studied caused bacteremia.
T19 1731-1743 Sentence denotes CONCLUSIONS:
T19 1731-1743 Sentence denotes CONCLUSIONS:
T20 1744-1878 Sentence denotes Multiple factors, including the infusate and the duration of cannulation, contribute to the development of infusion-related phlebitis.
T20 1744-1878 Sentence denotes Multiple factors, including the infusate and the duration of cannulation, contribute to the development of infusion-related phlebitis.
T21 1879-2121 Sentence denotes The use of peripheral intravenous catheters made of PEU-Vialon appears to pose the same risk for catheter-related infection as the use of catheters made of FEP-Teflon, and PEU-Vialon can permit longer cannulation with less risk for phlebitis.
T21 1879-2121 Sentence denotes The use of peripheral intravenous catheters made of PEU-Vialon appears to pose the same risk for catheter-related infection as the use of catheters made of FEP-Teflon, and PEU-Vialon can permit longer cannulation with less risk for phlebitis.
T22 2122-2344 Sentence denotes The risk for catheter-related bacteremia with FEP-Teflon and PEU-Vialon catheters is sufficiently low that it no longer seems justifiable to recommend the use of small steel needles for most peripheral intravenous therapy.
T22 2122-2344 Sentence denotes The risk for catheter-related bacteremia with FEP-Teflon and PEU-Vialon catheters is sufficiently low that it no longer seems justifiable to recommend the use of small steel needles for most peripheral intravenous therapy.